Degradation of muramyl dipeptide by mammalian serum
- PMID: 3876287
- PMCID: PMC262175
- DOI: 10.1128/iai.50.1.320-321.1985
Degradation of muramyl dipeptide by mammalian serum
Abstract
Muramyl dipeptide, N-acetylmuramyl-L-alanine-D-isoglutamine (MDP), is the minimal biologically active subunit of bacterial peptidoglycan and elicits an acute inflammation in vivo. We now report that MDP is degraded by normal rat serum into its constituents, N-acetylmuramic acid and L-alanine-D- isoglutamine. The dipeptide is further degraded into its components L-alanine and D-isoglutamine. These results may help to explain how inflammation elicited by MDP is terminated in vivo.
Similar articles
-
Pharmacokinetics and feeding responses to muramyl dipeptide in rats.Physiol Behav. 2003 Jul;79(2):173-82. doi: 10.1016/s0031-9384(03)00065-9. Physiol Behav. 2003. PMID: 12834788
-
Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.J Exp Med. 1981 Apr 1;153(4):1021-6. doi: 10.1084/jem.153.4.1021. J Exp Med. 1981. PMID: 6972989 Free PMC article.
-
Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.Hepatology. 1988 Sep-Oct;8(5):1046-50. doi: 10.1002/hep.1840080511. Hepatology. 1988. PMID: 2971013
-
Calreticulin is a binding protein for muramyl dipeptide and peptidoglycan in RK13 cells.Biochemistry. 2004 Sep 21;43(37):11796-801. doi: 10.1021/bi0490789. Biochemistry. 2004. PMID: 15362864
-
Muramyl peptides as possible endogenous immunopharmacological mediators.Microbiol Immunol. 1983;27(9):723-32. doi: 10.1111/j.1348-0421.1983.tb00636.x. Microbiol Immunol. 1983. PMID: 6358804 Review.
Cited by
-
Translation of peptidoglycan metabolites into immunotherapeutics.Clin Transl Immunology. 2019 Nov 29;8(12):e1095. doi: 10.1002/cti2.1095. eCollection 2019. Clin Transl Immunology. 2019. PMID: 31798878 Free PMC article. Review.
-
Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains.Infect Immun. 2000 Jun;68(6):3535-40. doi: 10.1128/IAI.68.6.3535-3540.2000. Infect Immun. 2000. PMID: 10816508 Free PMC article.
-
Elimination of group A streptococcal cell walls from mammalian tissues.Infect Immun. 1987 Jun;55(6):1526-8. doi: 10.1128/iai.55.6.1526-1528.1987. Infect Immun. 1987. PMID: 3553006 Free PMC article.
-
Strengthening peptide-based drug activity with novel glyconanoparticle.PLoS One. 2018 Sep 27;13(9):e0204472. doi: 10.1371/journal.pone.0204472. eCollection 2018. PLoS One. 2018. PMID: 30260999 Free PMC article.
-
Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening.Biomolecules. 2022 Jul 29;12(8):1054. doi: 10.3390/biom12081054. Biomolecules. 2022. PMID: 36008948 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources